To test the hypothesis of whether radiotherapy affects immunity against tumor cells in metastatic disease, low-dose fractionated local radiation was combined with NHS-IL2 treatment in a syngeneic LLC tumor model. This evidence concerns the gene IL2 and neoplasm.